Search our Site

Point of Care ToolsHeritable Thoracic Aortic Disease (HTAD)

Updated July 2024

htad

Here is a point of care tool containing a checklist to help you decide who should be considered for referral for genetic assessment.

 

 

  • HTAD accounts for ~20-25% of all thoracic aortic aneurysms and dissections.
  • Most individuals with HTAD do not have additional associated features (non-syndromic).
  • HTAD presents at a younger age and is more aggressive than other TAA.
  • Appropriate recognition of HTAD allows initiation of imaging surveillance in at-risk relatives.
  • A positive genetic test result can help guide pharmacotherapy, determine vascular regions which require ongoing imaging surveillance, influence surgical threshold, and allow for cascade testing of at-risk relatives.
  • In most families with HTAD, genetic testing does NOT identify the responsible genetic variant. Thus negative testing does not exclude HTAD and at-risk relatives would still need ongoing imaging surveillance.
  • Pharmacological management for those with TAA may include:
    • beta-blockers or angiotensin receptor blockers to limit aneurysmal dilation.
    • avoidance of medications and recreational drugs with potential vasoactive effect (e.g. triptans, cocaine).
  • Fluoroquinolones should be avoided as much as possible in anyone with aortic aneurysms or at risk for aortic aneurysm (thoracic or not, heritable or not), because of the associated increased risk of aortic dissectio
  • Participation in competitive sports and isometric exercises are advised against.
  • htad

More on HTAD can be found in the comprehensive GECKO deep dive and the concise GECKO on the run.

 

Highlight: What are others reading about on GECKO

A Guide to understanding prenatal screening

A Guide to understanding prenatal screening

A resource developed for pregnant persons and their providers. Everything you wanted to know about screening from deciding whether or not have it, to results…

Read more

Latest News

The GEC-KO team will be presenting at the 2021 University of Ottawa’s Annual Refresher Course

Have some questions about how Canada’s genetic non-discrimination act works and what it means for your practice?

Check out this 2022 article in Canadian Family Physician

Read more

Twitter